Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-022238

President and CEO sold 4,807 shares at $19.48 ($93,640)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2020-03-30 Sale −4,807 $19.48 $93,640 22,013 D
Open-market sales · 4,807 sh · avg $19.48 · $93,640
Loading xslF345X03/doc4.xml…